166 related articles for article (PubMed ID: 2504888)
1. Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid.
Gallo P; Piccinno MG; Pagni S; Argentiero V; Giometto B; Bozza F; Tavolato B
J Neurol Sci; 1989 Aug; 92(1):9-15. PubMed ID: 2504888
[TBL] [Abstract][Full Text] [Related]
2. A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-gamma in multiple sclerosis CSF and serum.
Gallo P; Piccinno MG; Tavolato B; Sidén A
J Neurol Sci; 1991 Feb; 101(2):227-32. PubMed ID: 1827837
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis: IL-2 and sIL-2R levels in cerebrospinal fluid and serum. Review of literature and critical analysis of ELISA pitfalls.
Sivieri S; Ferrarini AM; Gallo P
Mult Scler; 1998 Feb; 4(1):7-11. PubMed ID: 9532585
[TBL] [Abstract][Full Text] [Related]
4. In vivo relationship of interleukin-2 and soluble IL-2 receptor to blood-brain barrier impairment in patients with active multiple sclerosis.
Sharief MK; Hentges R; Ciardi M; Thompson EJ
J Neurol; 1993 Jan; 240(1):46-50. PubMed ID: 8423463
[TBL] [Abstract][Full Text] [Related]
5. The relationship of interleukin-2 and soluble interleukin-2 receptors to intrathecal immunoglobulin synthesis in patients with multiple sclerosis.
Sharief MK; Hentges R; Thompson EJ
J Neuroimmunol; 1991 Apr; 32(1):43-51. PubMed ID: 2002090
[TBL] [Abstract][Full Text] [Related]
6. Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission.
Shaw CE; Dunbar PR; Macaulay HA; Neale TJ
J Neurol; 1995 Jan; 242(2):53-8. PubMed ID: 7707089
[TBL] [Abstract][Full Text] [Related]
7. Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility.
Peter JB; Boctor FN; Tourtellotte WW
Neurology; 1991 Jan; 41(1):121-3. PubMed ID: 1985276
[TBL] [Abstract][Full Text] [Related]
8. Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis.
Sharief MK; Thompson EJ
J Neurol Neurosurg Psychiatry; 1993 Feb; 56(2):169-74. PubMed ID: 8437006
[TBL] [Abstract][Full Text] [Related]
9. High cerebrospinal fluid and serum levels of tumor necrosis factor-alpha in asymptomatic HIV-1 seropositive individuals. Correlation with interleukin-2 and soluble IL-2 receptor.
Ciardi M; Sharief MK; Thompson EJ; Salotti A; Vullo V; Sorice F; Cirelli A
J Neurol Sci; 1994 Sep; 125(2):175-9. PubMed ID: 7807163
[TBL] [Abstract][Full Text] [Related]
10. Elevated titers of cell-free interleukin-2 receptor in serum and cerebrospinal fluid specimens of patients with acquired immunodeficiency syndrome.
Sethi KK; Näher H
Immunol Lett; 1986 Oct; 13(4):179-84. PubMed ID: 3095229
[TBL] [Abstract][Full Text] [Related]
11. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.
Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA
J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis.
Ott M; Demisch L; Engelhardt W; Fischer PA
J Neurol; 1993 Dec; 241(2):108-14. PubMed ID: 8138825
[TBL] [Abstract][Full Text] [Related]
13. Soluble interleukin-2 receptor and soluble CD8 molecules in cerebrospinal fluid and serum of patients with multiple sclerosis.
Carrieri PB; Soscia E; Iacovitti B; Pellicano M; D'Antonio A; Provitera V; Perrella O
Eur Cytokine Netw; 1992; 3(5):495-8. PubMed ID: 1477299
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10, interferon gamma, interleukin-2, and soluble interleukin-2 receptor alpha detected during peritonitis in the dialysate and serum of patients on continuous ambulatory peritoneal dialysis.
Lu Y; Hylander B; Brauner A
Perit Dial Int; 1996; 16(6):607-12. PubMed ID: 8981529
[TBL] [Abstract][Full Text] [Related]
15. Prospective serial analysis of interleukin-2 and soluble interleukin-2 receptor in relapsing-remitting multiple sclerosis.
Freedman MS; Muth KL; Trotter JL; Yoshizawa CN; Antel JP
Neurology; 1992 Aug; 42(8):1596-601. PubMed ID: 1641157
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of cytokines and soluble cytokine receptors in various T-cell malignancies.
Raziuddin S; Sheikha A; Abu-Eshy S; al-Janadi M
Cancer; 1994 May; 73(9):2426-31. PubMed ID: 8168046
[TBL] [Abstract][Full Text] [Related]
17. T cell immune response is correlated with fibrosis and inflammatory activity in hepatitis B cirrhotics.
Tang JT; Fang JY; Gu WQ; Li EL
World J Gastroenterol; 2006 May; 12(19):3015-9. PubMed ID: 16718780
[TBL] [Abstract][Full Text] [Related]
18. Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha.
Nicoletti F; Di Marco R; Patti F; Zaccone P; L'Episcopo MR; Reggio E; Xiang M; Nicoletti A; Reggio A
Cytokine; 2000 Jun; 12(6):682-7. PubMed ID: 10843745
[TBL] [Abstract][Full Text] [Related]
19. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
Shaarawy M; Darwish NA; Abdel-Aziz O
J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment.
Ozenci V; Kouwenhoven M; Huang YM; Kivisäkk P; Link H
Clin Exp Immunol; 2000 Apr; 120(1):147-53. PubMed ID: 10759776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]